Posted by Michael Wonder on 27 May 2020
Trump tries to convince voters he’s lowered drug prices, based only on a modest tweak to Medicare
26 May 2020 - President Trump used a glitzy Rose Garden address, flanked by pharmaceutical company CEOs and patient advocates, to boast of his administration’s successes lowering drug prices and to detract from his political rivals’ efforts on the same issue.
But the news he was touting was modest at best: drug makers agreed to participate in a minor, voluntary Medicare program that will likely only provide a limited discount on insulin for a small subset of the 60 million seniors with Medicare coverage.
